OBJECTIVE: The objective of this work was to assess the Standardized Uptake Value (SUV) in the differential diagnosis of radiologically indeterminate lung lesions by means of ROC curves. MATERIAL AND METHOD: Forty seven patients were studied by Positron Emission Tomography with 18-fluorine-2-desoxy-D-glucose (FDG PET) analyzing the value of maximum SUV. The patients were classified into three groups. Group 1 = patients without previous neoplasia (WPN) + patients with previous neoplasia (PN). Group 2 = WPN. Group 3 = PN. RESULTS: The ROC curves showed a high diagnostic accuracy in the three groups, with area under the curve (AUC) values of 0.96, 0.98 and 0.91 respectively. The typical error was 0.03, 0.02 and 0.08. The maximum SUV cutoffs with the best diagnostic accuracy for the three groups were: 2.6; 3 and 2.4, with an accuracy (A) of 93.6%, 97% and 92.3%, respectively. Analyzing all the patients globally (group 1), we obtained one false positive result in a patient with hamartoma (max SUV = 2.8) and two false negative results in one patient with lung metastases from malignant fibrohistiocytoma (max SUV = 0.7) and in another patient with lung metastases from unknown origin adenocarcinoma (max SUV = 1.9). CONCLUSIONS: FDG PET permits differentiation with a very high diagnostic accuracy of benign and malignant lung lesions using the maximum SUV. The differences observed between the different groups are due to the different disease prevalence, obtaining a lower negative predictive value of max SUV in patients with previous neoplasia.

Adult↗

PubMedDate not supplied

[Impact of positron emission tomography with FDG-PET in treatment of patients with suspected recurrent ovarian cancer].

AIM: Recurrent ovarian cancer is a major problem and an accurate diagnosis can often change patients' management. This study aimed to assess the impact on management of FDG-PET in recurrent ovarian cancer. MATERIAL AND METHODS: Forty-three patients in whom FDG-PET scan was performed due to suspected recurrent ovarian cancer were included. FDG-PET results were confirmed by histopathology and clinical follow-up of at least 12 months. To assess impact on management the treatment plan based on conventional imaging methods was compared with the treatment plan based on inclusion of PET findings, classifying FDG-PET impact on management as high, medium, low or no impact. Management changes, when present, were classified as intermodality or intramodality. RESULTS: FDG-PET had a high impact on therapeutic management in 28 patients (65.1 %), medium impact in 2 patients (4.6 %), low impact in 9 patients (20.9 %), and no impact in 4 patients (9.3 %). FDG-PET induced an intermodality change in management in 27 patients (62,8 %); intramodality changes were induced in 3 patients (7 %). Finally, it produced no treatment changes in 13 patients (30.2 %). CONCLUSION: FDG-PET supplied additional information when compared to conventional diagnostic procedures and allowed adequate management changes in most patients.

Adult↗

PubMedDate not supplied

[Neuroimaging in epilepsy. Advances in SPECT and PET in epilepsy].

INTRODUCTION: The incorporation of neuroimaging techniques into the protocol for localization of epileptogenous foci has considerably reduced the need for use of intracranial electrodes. DEVELOPMENT: SPECT and PET are most useful in cases of epilepsy with no cerebral morphological anomalies, in which there are therefore no changes which shown on MR. Cerebral SPECT with perfused tracers, such as 99mTc-HMPAO, 123I-MP or 99mTc-ECD, permit the study of patients during interictal and perictal phases. In the latter case, although the procedure is complex, one may observe an increase in cerebral blood flow in the epileptogenous focus in 90% of the patients. PET with FDG allows interictal study of patients, and shows reduced metabolism in the epileptogenic region. By comparison with video-EEG there are S = 84% and SP = 86% in temporal lobe epilepsy. The diagnostic efficiency of these two techniques is rather less in the localization of extratemporal foci and in multifocal epilepsies, although it is always better than with other diagnostic techniques. They have also been shown to be useful in the prognosis of functional recovery after surgery. CONCLUSION: The possibility of studying neuroreceptors may be of great use in the investigation of the etiopathogenesis of epilepsy, and thus lead to improvement in the clinical and therapeutic management of patients. With SPECT, 123I-Iomacenil and 123I-lododexetimide are used. With PET and 11C-Carfentanyl opiate receptors have been studied. With 11C-Fluomacenil one may study the cerebral distribution of the benzodiazepine receptors.

Brain↗